Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease
出版年份 2023 全文链接
标题
Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease
作者
关键词
-
出版物
BIOORGANIC CHEMISTRY
Volume 140, Issue -, Pages 106830
出版商
Elsevier BV
发表日期
2023-09-06
DOI
10.1016/j.bioorg.2023.106830
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advances in the Omicron variant development
- (2022) Antonio Vitiello et al. JOURNAL OF INTERNAL MEDICINE
- Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
- (2022) Haozhou Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
- (2022) Jing Lian Suah et al. Emerging Microbes & Infections
- Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models
- (2021) Yingjun Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
- (2021) Jerzy Osipiuk et al. Nature Communications
- Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
- (2021) Ewelina Weglarz-Tomczak et al. Scientific Reports
- A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease
- (2021) Stephanie Patchett et al. Cell Reports
- Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
- (2021) Chunlong Ma et al. ACS Central Science
- Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
- (2021) Sarah Huff et al. JOURNAL OF MEDICINAL CHEMISTRY
- Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection
- (2021) Deeksha Munnur et al. NATURE IMMUNOLOGY
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
- (2021) Caleb D. Swaim et al. iScience
- Understanding evolution of SARS‐CoV‐2: a perspective from analysis of genetic diversity of RdRp gene
- (2020) Sunitha M. Kasibhatla et al. JOURNAL OF MEDICAL VIROLOGY
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
- (2020) Daniel W. Kneller et al. Nature Communications
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Ebselen, a new candidate therapeutic against SARS-CoV-2
- (2020) C.V. Haritha et al. International Journal of Surgery
- A protein structure-guided covalent scaffold selectively targets the B1 and B2 subclass metallo-β-lactamases
- (2018) Cheng Chen et al. CHEMICAL COMMUNICATIONS
- Target discovery of ebselen with a biotinylated probe
- (2018) Zhenzhen Chen et al. CHEMICAL COMMUNICATIONS
- Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo
- (2018) Jianpeng Su et al. BIOORGANIC CHEMISTRY
- NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine
- (2016) Nicholas C.K. Valerie et al. CANCER RESEARCH
- Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1)
- (2015) Jiachi Chiou et al. CHEMICAL COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More